Transplantation: Are Calcineurin Inhibitors Safer Than mTOR Inhibitors?

Nature Reviews Nephrology - United Kingdom
doi 10.1038/nrneph.2012.262
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Conversion From Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplantation: A Single Centre Experience

Turkish Nephrology, Dialysis and Transplantation Journal
SurgeryUrology
2014English

Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2014English

Are Calcineurin Inhibitors-Free Regimens Ready for Prime Time?

Kidney International
Nephrology
2012English

New Perspectives on mTOR Inhibitors (Rapamycin, Rapalogs and TORKinibs) in Transplantation

British Journal of Clinical Pharmacology
Pharmacology
2016English

Comparison of Calcineurin Inhibitors With M-Tor Inhibitors in Renal Transplant Patients

Akdeniz Medical Journal
2015English

Calcineurin Inhibitors: 40 Years Later, Can't Live Without ...

Journal of Immunology
AllergyImmunology
2013English

Impact of Calcineurin Inhibitors on Rat Glioma Cells Viability

Yeungnam University Journal of Medicine
2019English

The Use of Topical Calcineurin Inhibitors in Atopic Dermatitis

Open Dermatology Journal
Dermatology
2014English

Rapalogs and mTOR Inhibitors as Anti-Aging Therapeutics

Journal of Clinical Investigation
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy